Package Leaflet: Information for the PatientIbandronic Acid Bluefish 150 mg Film-Coated Tablets EFG
Ibandronic Acid
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.Keep this leaflet. You may need to read it again.
Contents of thepackage leaflet:
Ibandronic Acid Bluefish belongs to a group of medicines called bisphosphonates.It contains the active substance ibandronic acid.
Ibandronic Acid Bluefish can reverse bone loss, as it prevents further bone loss and increases bone mass in most women who take it, even if they cannot see or appreciate the difference. Ibandronic Acid Bluefish may help reduce the number of bone fractures (fractures). This reduction has been demonstrated in vertebral fractures, but not in hip fractures.
You have been prescribedIbandronic Acid Bluefish to treat your postmenopausal osteoporosis because you are at high risk of suffering fractures.Osteoporosis is a condition where bones become thinner and weaker, often occurring in women after menopause. During menopause, the ovaries stop producing the female hormone — estrogen — which helps maintain bone health.
The earlier a woman reaches menopause, the higher the risk of suffering fractures due to osteoporosis. Other factors that increase the risk of fractures include:
Healthy lifestyle habitsalso facilitate the beneficial effects of treatment. These include a balanced diet rich in calcium and vitamin D; walking or any other weight-bearing exercise; not smoking; and moderate alcohol consumption.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting treatment with Ibandronic Acid Bluefish.
A rare adverse reaction called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported during post-marketing experience in patients treated with Ibandronic Acid Bluefish for osteoporosis. ONJ may also occur after treatment is discontinued.
It is essential to try to prevent the development of ONJ, as it is a painful condition that can be challenging to treat. To reduce the risk of developing osteonecrosis of the jaw, certain precautions should be taken.
Before receiving treatment, inform your doctor/nurse (healthcare professional) if:
Your doctor may ask you to undergo a dental examination before starting treatment with Ibandronic Acid Bluefish.
While you are being treated, you must maintain good oral hygiene (including regular toothbrushing) and undergo routine dental check-ups. If you wear dentures, ensure they fit properly. If you are undergoing dental treatment or are about to undergo dental surgery (e.g., tooth extraction), inform your doctor about your dental treatment and inform your dentist that you are being treated with Ibandronic Acid Bluefish.
Contact your doctor and dentist immediately if you experience any problems in your mouth or teeth, such as tooth loss, pain, or swelling, or difficulty healing ulcers or discharge, as these may be signs of osteonecrosis of the jaw.
Atypical fractures of the long bones, such as the forearm (ulna) and tibia, have also been reported in patients receiving long-term treatment with ibandronic acid. These fractures occur after minimal or no trauma, and some patients experience pain in the area of the fracture before a complete fracture occurs.
Some people require special care during treatment with Ibandronic Acid Bluefish. Consult your doctor before taking Ibandronic Acid Bluefish:
Irritation, inflammation, or ulceration of the throat/esophagus may occur, often with symptoms of severe chest pain, severe pain after swallowing food or drink, severe nausea, or vomiting, especially if patients do not drink a full glass of water and/or lie down before one hour has passed after taking Ibandronic Acid Bluefish. If you develop these symptoms, stop taking Ibandronic Acid Bluefish and inform your doctor immediately (see section 3).
Children and adolescents
Do not give Ibandronic Acid Bluefish to children or adolescents under 18 years of age.
Othermedicines and Ibandronic Acid Bluefish
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines. Especially:
After taking the monthly Ibandronic Acid Bluefish tablet, wait 1 hour before taking any other medicine, including antacids, calcium supplements, and vitamins.
Ibandronic Acid Bluefish with food and drinks
Do not take Ibandronic Acid Bluefish with food. Ibandronic Acid Bluefish loses its effectiveness if taken with food.
You can drink water, but not other liquids
After taking Ibandronic Acid Bluefish, wait 1 hour before taking your first meal and other drinks (see the point 3. How to take Ibandronic Acid Bluefish)
Pregnancy and breastfeeding
Ibandronic Acid Bluefish is only for use in postmenopausal women and should not be taken by women of childbearing age.
Do not take Ibandronic Acid Bluefish if you are pregnant or breastfeeding.
Consult your doctor or pharmacist before using this medicine.
Driving and using machines
You can drive and use machines, as Ibandronic Acid Bluefish is not expected to have a significant effect on your ability to drive and use machines.
Ibandronic Acid Bluefish contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Ibandronic Acid Bluefish contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet;this is, essentially “sodium-free”.
The usual dose of Ibandronic Acid Bluefish is one tablet per month.
How to take the monthly tablet
It is essential that you follow these instructions carefully. They are designed to ensure that Ibandronic Acid Bluefish reaches the stomach quickly and causes less irritation.
Take the Ibandronic Acid Bluefish tablet
Do nottake the tablet with water that has a high concentration of calcium, fruit juice, or other drinks. If you are unsure about the potentially high calcium levels in your tap water (hard water), it is recommended to use bottled water with low mineral content.
During the next hour (60 minutes)after taking the tablet
Continuationof treatment with Ibandronic Acid Bluefish
It is essential that you take Ibandronic Acid Bluefish every month, until your doctor tells you to stop. Ibandronic Acid Bluefish only works to treat osteoporosis while you are taking this medicine. After 5 years of taking Ibandronic Acid Bluefish, consult your doctor to see if you should continue taking Ibandronic Acid Bluefish.
If you take more Ibandronic Acid Bluefishthan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you have taken an extra tablet by mistake, drink a full glass of milk and inform your doctor immediately.
Do not induce vomiting or lie downbecause it could irritate the esophagus.
It is recommended to bring the package leaflet and the medicine packaging to the healthcare professional.
If you forget to take Ibandronic Acid Bluefish
Instead, consult your calendar to see when your next dose is due:
Never take two Ibandronic Acid Bluefish tablets within the same week. Wait until your next scheduled dose and take it as usual, then continue taking one tablet per month according to the days marked on your calendar.
If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking Ibandronic Acid Bluefish and inform your doctor immediately if you experience any of the following serious side effects
Tell your doctor or nurse immediately if you notice any of the following serious side effects, as you may need urgent medical treatment:
Other possible side effects
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1000 people)
Frequency not known(cannot be estimated from the available data):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require special storage conditions.
Do not use this medicine after the expiry date stated on the packaging after “EXP.” The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to the pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Ibandronic Acid Bluefish
Core of the tablet: povidone, microcrystalline cellulose, pregelatinized corn starch, crospovidone, anhydrous colloidal silica, glycerol dibehenate;
Coating of the tabletcomposed of Opadry OY-LS-28908 (White II) which contains hypromellose (E464), lactose monohydrate, titanium dioxide (E171), macrogol.
Appearance of the Product and Container Content
Ibandronic Acid Bluefish 150 mg film-coated tablets, white, biconvex, 11.2±0.1mm in diameter.
Package sizes: 1 and 3 tablets
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Bluefish Pharmaceuticals AB
P.O. Box 49013,
100 28 Stockholm
Sweden
Manufacturer
Bluefish Pharmaceuticals AB
Gävlegatan 22
113 30 Stockholm
Sweden
Pharmathen S.A.
Dervenakion 6, Pallini Attiki, 15351,
Greece
Pharmathen International S.A
Industrial Park Sapes Rodopi Prefecture,
Block No 5, Rodopi, 693 00,
Greece
Further information about this medicinal product can be obtained from the local representative of the marketing authorization holder
Bluefish Pharma S.L.U., AP 36007
2832094 Madrid, Branch 36
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Germany Ibandronate Bluefish 150 mg Filmtabletten
Portugal Ibandronic Acid Bluefish 150 mg film-coated tablets
Sweden Ibandronate Bluefish 150 mg film-coated tablets
Date of the last revision of this leaflet:October 2024
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/